ng-nitroarginine methyl ester has been researched along with Conductive Hearing Loss in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anniko, M; Popa, R; Takumida, M | 1 |
1 other study(ies) available for ng-nitroarginine methyl ester and Conductive Hearing Loss
Article | Year |
---|---|
Otoprotectant minimizes hearing defects caused by Pseudomonas aeruginosa exotoxin A.
Topics: Animals; Auditory Threshold; Cochlea; Dizocilpine Maleate; Enzyme Inhibitors; Evoked Potentials, Auditory, Brain Stem; Exotoxins; Hearing Loss, Conductive; Hearing Loss, High-Frequency; Hearing Loss, Sensorineural; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Severity of Illness Index | 2000 |